Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Intuniv Tablets drug use-results survey (Surveillance regarding pediatric use)

Trial Profile

Intuniv Tablets drug use-results survey (Surveillance regarding pediatric use)

Phase of Trial: Phase IV

Latest Information Update: 09 May 2018

At a glance

  • Drugs Guanfacine (Primary)
  • Indications Attention-deficit hyperactivity disorder
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Shionogi
  • Most Recent Events

    • 07 May 2018 Status changed from not yet recruiting to recruiting.
    • 18 Apr 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top